Latest Small Cap Feast

Small Cap Feast

Small Cap Feast – 21 February 2020

Set Menu AIM:

Total number of AIM Companies (Incl Susp):

Total number of AIM Companies trading: *
* As at

Set Menu NEX Growth:

Total number of NEX Growth Market Companies (Incl Susp): *

Total number of NEX Growth Market Companies trading: *
* As at

Set Menu Standard List:

Total number of Standard List Companies (Incl Susp): *

Total number of Standard List Companies trading: *
* As at

Dish of the Day:

Investment firm Nippon Active Value (NAVF.L) raised £103m at an issue price of 100p per share via an IPO.   The company aims to invest in a portfolio of quoted Japanese stocks with market capitalisations of up to $1bn.   Main Mkt Premium.


Off the Menu:

No Leavers Today


Dish of the Day:

Off the Menu:

What’s Cooking in the IPO Kitchen?


FRP  Advisory Group, UK professional services firm specialising in restructuring advisory. Raising £80m (£20m primary). Expected market cap £190m.  Compound annual growth of 16.4 per cent. in revenue and 10.9 per cent. in operating profit since the beginning of FY17.o  Strong average EBITDA margins of 51 per cent. over FY17 to FY19, and consistently strong cash conversion

Inspecs, a UK designer, manufacturer and distributor of eyewear frames to global retail chains announces its intention to IPO onto AIM raising £94m with a market cap of £138m.  Admission expected 27th February.  FY Dec 2018 numbers show revenue of $57m and underlying EBITDA of $11m

Main Market (Standard List)

The Proof Of Trust has announced its intention to list on the Standard Market.  The Blockchain based business, owns patents to a protocol which facilitates dispute resolution based upon smart contract disputes.  Transaction details TBC.

Main Market (Premium)

DRI Healthcare—investment company focused on investments in healthcare Royalty Assets  looking to raise $350m. Due 11 Mar.

Ninety One –proposed demerger and public listing of  Investec’s  global asset management business on LSE and JSE. 30 Sep 2019 AUM £121bn. Sale of existing shares. Expected free float of >60%. Due 16 march.

Cabot Square—Closed ended investment fund focussed on alternative assets and asset manager. Looking to raise £200m.  Will target investment opportunities that are expected to generate an attractive risk adjusted return and that can also make a positive ESG impact by focusing on some of the biggest challenges facing societies and economies.  Due 14 Feb.

The Global Sustainable Farmland Income Trust will invest in a diversified portfolio of operational farmland assets located in major agricultural markets including the United States, Europe, New Zealand, Australia and certain countries within Latin and South America. Raising up to $300m.   Due 28 February.

NEX Exchange

Incanthera—Specialist oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive . Due 28 Feb.

Zapp Scooters, a developer and manufacturer of electric two-wheeled vehicles announced its intention to IPO on the NEX Exchange Growth Market.  The Company intends to raise up to £3.5m. Admission is expected to occur on NEX in February 2020.


Breakfast Buffet

Ariana Resources (AAU.L) 3.4p £36m

 Operating results for the quarter ended 31 December 2019 for the Kiziltepe Mine .

Gross income for the year is US$45.1 million from production of 27,985 ounces of gold, exceeding its full year production guidance of 25,000 ounces of gold by 2,985 ounces; representing an increase of c. 12%.


  • Record gross quarterly income of US$12.78 million at an average realised gold price of US$1,484 per ounce, against an average revenue per gold ounce of US$1,736 due to silver credit).

 Production and sale of 7,318 ounces of gold during the quarter ending 31 December 2019.

 Operating cash costs for the quarter are estimated at US$500 per ounce#.

Operational mill availability running at 99% and utilisation at 97% during December.

54,735 tonnes ore milled during the period ending 31 December 2019 at an average head grade of 4.42 g/t Au.

Process recovery of gold remains high at 92%.


AdEPT Tech (ADT.L) 322p £76.3m

Proposed placing and subscription to raise gross proceeds up to £4.0 million  at 320p.

Net proceeds of the Placing and Subscription will be used in support of the Company’s stated strategy to reduce indebtedness, finance potential acquisition opportunities, accelerate Project Fusion “One AdEPT” and for ongoing working capital requirements . Alongside the delivery of long term, sustainable organic growth, the Board believes that selective acquisitions will continue to provide an expedited route to growth. This may be to accelerate product and technology capability and / or broaden AdEPT’s geographic footprint. Any acquisition activity would be judged against defined strategic, operational, financial and cultural criteria before being considered for further investigation.


Bagir Group (BAGR.L) 0.525p £1.6m

The designer, creator and provider of innovative tailoring, confirms that it has resolved to take legal action against the Shandong Ruyi Group for breach of contract. On 19 June 2019, the Company announced, with regard to Shandong Ruyi’s remaining cash payment of $13.2m, that the Company had agreed to a further extension of the unconditional* completion date to 31 March 2020. The transaction was first announced on 23 November 2017.The extension of the unconditional completion date to 31 March 2020 was conditional on Shandong Ruyi providing suit jacket manufacturing equipment, with an estimated market value of approximately $1.3 million, for nil consideration, for use in Bagir’s Ethiopian manufacturing facility, by the end of September 2019. The manufacturing equipment has not, however, been delivered, to date. This further failure by Shandong Ruyi constitutes a material breach of the terms of the contract.

Whilst trading conditions have remained challenging, the Company continued to generate good sales growth for FY Dec 2019, up 9 % to $ 59 .4 m (2018: $54.6m) and expects to deliver a return to positive adjusted EBITDA (2018: negative adjusted EBITDA $1.0m).


600 Group (SIXH.L) 11.5p £13.5m

 In December the Group reported that it had been experiencing certain macro-economic and political uncertainties across its end markets, particularly in the Far East and automotive markets, with order intake for the fourth quarter expected to be significantly below originally predicted levels. Traing conditions have since become more challenging with the combination of the General Motors strike in USA plants at the end of last year and the suspension of manufacture by Boeing of its 737 MAX in January this year  further impacting hundreds of thousands of suppliers across our core industrial markets. Order intake in both Machine Tools and Industrial Laser Systems therefore remains volatile, including two significant projects that have been pushed into the next financial year. In addition, the Coronavirus is causing disruption to shipping from the Far East.

Thereforethe full year is now expected to be significantly below the Board’s previously revised expectations.


Despite these major headwinds, the Board continues to believe in the long-term fundamentals of the Group, 


Two Shields (TSI.L) 0.105p £4.7m

 Investee Company, BrandShield, a leading provider of services from brand protection to online threat hunting, announces the launch of its ElectionShield product to protect political campaigns from online threats such as fraudulent fundraising sites; phishing; social phishing; and impersonation .

“ElectionShield will be officially launched at one the World’s leading cybersecurity events, the RSA Conference in San Francisco, on February 24 – 28, 2020. BrandShield is exhibiting at South Expo, Booth# 3119. ElectionShield utilizes BrandShield’s market-leading technology to protect political campaigns and candidates from a growing range of online threats. These include social impersonation; fraudulent fundraising schemes; domain squatting; sale of unauthorized merchandise; fake social media content; phishing, social phishing and fake news.  The last few years have seen a proliferation of fake social media content, in some cases using ‘deep fake’ video, designed to attack politicians. “.


Walcom Group (WALG.L) 0.3p £0.2m

Update on the Company’s working capital position.

As previously announced, Mr Francis Chi, Chief Executive Officer of the Company, has indicated that he intends to provide a loan of HK$1,230,000 to Walcom Bio-Chemicals Industrial Limited, Walcom’s wholly owned subsidiary. Whilst the Board understands that is still Mr Francis Chi’s intention to provide the loan, it has still not been received. The Company continues to receive new customer orders which is benefitting its working capital position.  In addition, the Company has negotiated an extension to the time for the payment of rent, salaries and other expenses which are currently due in the very short term such that these expenses can be partially and gradually paid over the coming weeks.  As a result, the Board now believes that in the absence of the loan being received in part or in full by 6 March 2020, the Company may be unable to continue its operations and would be forced into liquidation with a consequential diminution in value to shareholders.


Oilex (OEX.L) 0.16p £5.5m

Doriemus plc (Doriemus) has successfully completed a conditional bookbuild to raise A$4.5 million via a placement of Doriemus shares and options (Placement).

The Placement by Doriemus will, upon completion, satisfy a key condition precedent to the proposed acquisition by Doriemus of the Company’s portfolio of Cooper-Eromanga Basin assets, as detailed in the Company’s announcement on 29 January 2020 (“Acquisition”). The Acquisition remains subject to a number of other conditions precedent as set out in the same announcement.


Arricano Real Estate(ARO.L) 0.45p £46.5m

Arricano first announced a new loan facility for its wholly owned subsidiary Comfort Market Luks LLC, which operates the Kyiv Prospekt Shopping and Entertainment Complex, with Public Joint Stock Company “State Savings Bank of Ukraine” on 26 July 2019.

Arricano announced today that, having satisfied the conditions precedent, it yesterday drew down a further USD2.5 million of the remaining USD12.2 million available under the Facility. Further drawdowns under the facility, unless price sensitive, will be aggregated and reported on in the Company’s annual and interim reports.

This drawdown will be utilised to finance ongoing construction of the Lukianivka Shopping and Entertainment Center in Kyiv.


Fulcrum Utility Services (FCRM.L) 23.75p £52.8m

Appointment of Ian Pattison as Interim Chief Financial Officer (CFO). Ian will join the Company on 24 February 2020 and commence his role as an executive director, a non-board position.

Ian brings significant experience with him, having held senior financial roles at Clugston Group, Cintas Document Management, Cape Plc and Boeing (Australia.


Oncimmune (ONC.L) 61.5p £38.9m

Award of  the ‘Winning in Business in Spain’ award at the Department for International Trade’s (DIT) UK-Spain Business Awards held on 20th February 2020 at the Madrid Stock Exchange in Spain.

The DIT’s introduction of Sabartech has enabled Oncimmune to build its successful distribution partnership with Sabartech, which has led to making EarlyCDT Lung available in Spain and Portugal.


Head Chef:

Derren Nathan
0203 764 2344

*A corporate client of Hybridan LLP


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email with “unsubscribe me”.